Disclosures:
- Employment: University of California Irvine:Professor and Chair:Employee;University of California Davis:Professor of Clinical Radiation Oncology:Employee
- Compensation: Bristol Myer Squibb: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: November 2024 ;Novocure: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria-End Date: November 2024 ;Astra Zeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria, Travel Expenses-End Date: Feb 2026 ;Dava: Honoraria-End Date: Oct 2024 ;Genentech: Research Grants, Research Funding, Research Salary Support, Grant Resear
- Ownership: none
- Leadership: Clinical Lung Cancer:Editorial board member;NCI:Co-Chair;Clinical Lung Cancer:Editorial board member;IJROBP:Associate Editor